首页> 外文期刊>Cancer science. >Droplet digital polymerase chain reaction assay and peptide nucleic acid‐locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T‐cell lymphoma
【24h】

Droplet digital polymerase chain reaction assay and peptide nucleic acid‐locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T‐cell lymphoma

机译:血管免疫细胞淋巴瘤中RHOA突变检测的液滴数字聚合酶链反应测定和肽核酸锁定核酸钳钳方法

获取原文
           

摘要

Angioimmunoblastic T‐cell lymphoma (AITL) is a subtype of nodal peripheral T‐cell lymphoma (PTCL). Somatic RHOA mutations, most frequently found at the hotspot site c.50G?>?T, p.Gly17Val (G17V RHOA mutation) are a genetic hallmark of AITL. Detection of the G17V RHOA mutations assists prompt and appropriate diagnosis of AITL. However, an optimal detection method for the G17V RHOA mutation remains to be elucidated. We compared the sensitivity and concordance of next‐generation sequencing (NGS), droplet digital PCR (ddPCR) and peptide nucleic acid‐locked nucleic acid (PNA‐LNA) clamp method for detecting the G17V RHOA mutation. G17V RHOA mutations were identified in 27 of 67 (40.3%) PTCL samples using NGS. ddPCR and PNA‐LNA clamp method both detected G17V mutations in 4 samples in addition to those detected with NGS (31 of 67, 46.3%). Additionally, variant allele frequencies with ddPCR and those with NGS showed high concordance ( P ?T;50G?>?T], p.Gly17Leu in PTCL198; c.[50G?>?T;51A?>?C], p.Gly17Val in PTCL216; and c.50G?>?A, p.Gly17Glu in PTCL223) were detected using NGS. These sequence changes could not appropriately be detected using the ddPCR assay and the PNA‐LNA clamp method although both indicated that the samples might have mutations. In total, 34 out of 67 PTCL samples (50.7%) had RHOA mutations at the p.Gly17 position. In conclusion, our results suggested that a combination of ddPCR/PNA‐LNA clamp methods and NGS are best method to assist the diagnosis of AITL by detecting RHOA mutations at the p.Gly17 position.
机译:血管免疫细胞淋巴瘤(AIT1)是节点外周T细胞淋巴瘤(PTCL)的亚型。体细胞rhOA突变,最常发现在热点位点C.50G?> T,P.Gly17Val(G17V RhoA突变)是Ait1的遗传标志。检测G17V RhOA突变有助于提示和适当诊断AIT1。然而,仍有待阐明G17V RhOA突变的最佳检测方法。我们比较了下一代测序(NGS),液滴数字PCR(DDPCR)和肽核酸锁定核酸(PNA-LNA)夹紧方法的敏感性和一致性,用于检测G17V RhOA突变。使用NGS在67个(40.3%)PTCL样品中的27例中鉴定G17V rhOA突变。除了用NGS检测到的那些外,DDPCR和PNA-LNA钳位方法还检测到4个样品中的G17V突变(3167,46.3%)。另外,具有DDPCR的变异等位基因频率和NGS的等位基因频率显示出高的一致性(P?T; 50G?>ΔT],P.Gly17Leu在PTC1198中; C. [50g吗?>Δt; 51a?>?c],p。使用NGS检测PTCL216中的GLY17VAL;和C.50G?>?A,P.GLY17GLU)使用NGS检测到pTCL223中。使用DDPCR测定和PNA-LNA钳位方法无法检测到这些序列变化,尽管两者都表明样品可能具有突变。总共34种PTCL样品(50.7%)在P.Gly17位置具有RhOA突变。总之,我们的结果表明DDPCR / PNA-LNA钳位方法和NGS的组合是通过检测P.GLY17位置的RHOA突变来帮助诊断AIT1的最佳方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号